23.05
Castle Biosciences Inc (CSTL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
2.05%
86.19
|
87.99 | 85.78 | 87.00 | 72.97 |
Cost Of Revenue |
7.59%
17.63
|
16.38 | 15.61 | 14.52 | 13.89 |
Gross Profit |
4.25%
68.56
|
71.61 | 70.17 | 72.48 | 59.08 |
|
26.85%
72.81
|
99.53 | 65.09 | 67.47 | 64.55 |
Interest Income/Expense |
12.50%
0.009
|
0.008 | 0.192 | 0.216 | 0.014 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
21.98%
90.44
|
115.92 | 80.70 | 81.99 | 78.44 |
Operating Income/Loss |
84.78%
-4.251
|
-27.93 | 5.079 | 5.012 | -5.471 |
Income/Loss From Continuing Operations Before Tax |
433.44%
86.19
|
-25.85 | 85.78 | 8.92 | -2.534 |
Income Tax Expense/Benefit, Deferred |
506.10%
-4.667
|
-0.77 | 5.25 | -1.542 | - |
Income Tax Expense/Benefit |
1,003%
-4.666
|
-0.423 | 6.013 | -1.034 | 0.045 |
Income/Loss From Continuing Operations After Tax |
117.50%
4.523
|
-25.85 | 2.269 | 8.92 | -2.534 |
|
117.50%
4.523
|
-25.85 | 2.269 | 8.92 | -2.534 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.07%
28.91
|
28.61 | 27.84 | 27.65 | 27.48 |
Diluted Average Shares |
3.27%
29.55
|
28.61 | 29.40 | 28.74 | 27.48 |
Basic Earnings Per Share |
117.78%
0.16
|
-0.90 | 0.08 | 0.32 | -0.09 |
Diluted Earnings Per Share |
116.67%
0.15
|
-0.90 | 0.08 | 0.31 | -0.09 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):